NKTR
Nektar Therapeutics · Healthcare
Chief R, D Officer Jonathan Zalevsky sold $50K of Nektar Therapeutics
Sold$50,266
$4.76Price
10,560Shares
−3%Stake
What NKTR did after the filing
- The stock from Wed, Aug 17 close, $70.80
- −35.6%
- S&P 500, same days
- −14.6%
Measured over 30 trading days, to the Sep 29 close.
Traded Tue, Aug 16. Filed Wed, Aug 17, 3:41 PM ET, during the session. Returns use the Aug 17 close and the Sep 29 close. Not investment advice.